{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:59:01Z","timestamp":1780894741503,"version":"3.54.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoproliferative disease that occurs in recipients of solid organ or hematopoietic stem cell transplants, resulting from the malignant transformation of benign proliferative lymphoid or plasma cell tissue due to immunosuppression. As an immunodeficiency-associated lymphoproliferative disorder, PTLD can affect various organs, including lymph nodes, the gastrointestinal tract, lungs, kidneys, and the central nervous system. The overall prognosis is generally poor. This case report describes a 37-year-old female patient presenting with magnetic resonance imaging (MRI) findings mimicking Bal\u00f3\u2019s concentric sclerosis (BCS). However, pathological biopsy confirmed a diagnosis of monomorphic Primary Central Nervous System PTLD (PCNS-PTLD). The patient was treated with immunosuppression reduction combined with rituximab plus lenalidomide which led to a partial remission. Both PTLD and Bal\u00f3\u2019s concentric sclerosis exhibit significant improvement with high-dose corticosteroid therapy, which can complicate the differential diagnosis. This report aims to summarize the clinical features of a case of PCNS-PTLD that mimicked Bal\u00f3\u2019s concentric sclerosis to enhance the early recognition and diagnosis of PCNS-PTLD.<\/jats:p>","DOI":"10.3389\/fonc.2026.1819442","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:54Z","timestamp":1780892634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Post-transplant lymphoproliferative disorder mimicking Bal\u00f3\u2019s concentric sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaofeng","family":"Xiong","sequence":"first","affiliation":[{"name":"Department of Neurology, Shenzhen People's Hospital, The Second Clinical Medical College, Jinan University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital (Shenzhen People\u2019s Hospital), School of Medicine, Southern University of Science and Technology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen Third People\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen Bao\u2019an Shiyan People\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shenzhen People\u2019s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70052-3","article-title":"Bal\u00f3\u2019s concentric sclerosis","volume":"13","author":"Hardy","year":"2014","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012230","article-title":"Clinical and radiologic features, pathology, and treatment of Bal\u00f3 concentric sclerosis","volume":"97","author":"Jolliffe","year":"2021","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","article-title":"Pathology of demyelinating diseases","volume":"7","author":"Popescu","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu Rev Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18763","article-title":"Post-transplant lymphoproliferative disorder: update on treatment and novel therapies","volume":"201","author":"Atallah-Yunes","year":"2023","journal-title":"Br J Haematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.01.015","article-title":"Posttransplant lymphoproliferative disorder following kidney transplantation: a review","volume":"78","author":"Sprangers","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.22056","article-title":"Radiologic differentiation of primary CNS posttransplant lymphoproliferative disorder from brain metastasis","volume":"215","author":"White","year":"2020","journal-title":"AJR Am J Roentgenology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2024.02.030","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: a case report and systematic review of imaging findings","volume":"19","author":"Hoyt","year":"2024","journal-title":"Radiol Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2017-0096","article-title":"Balo\u2019s concentric sclerosis: an update and comprehensive literature review","volume":"29","author":"Amini Harandi","year":"2018","journal-title":"Rev Neurosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117570","article-title":"Bal\u00f3\u2019s concentric sclerosis \u2013 A rare entity within the spectrum of demyelinating diseases","volume":"428","author":"Xie","year":"2021","journal-title":"J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86059","article-title":"Balo concentric sclerosis: a rare variant of multiple sclerosis with excellent response to early steroid treatment","volume":"17","author":"Luan","year":"2025","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001677","article-title":"Primary central nervous system post-transplant lymphoproliferative disorder with few specific abnormal findings observed on MRI and in the cerebrospinal fluid","volume":"62","author":"Takeuchi","year":"2022","journal-title":"Rinsho Shinkeigaku"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e31828cf619","article-title":"A case series of primary central nervous system posttransplantation lymphoproliferative disorder: Imaging and clinical characteristics","volume":"72","author":"Lake","year":"2013","journal-title":"Neurosurgery"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95037","article-title":"A case of primary central nervous system lymphoma mimicking a demyelinating disorder: from steroids to stem cell transplant","volume":"17","author":"Tanigundala","year":"2025","journal-title":"Cureus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12883-016-0596-1","article-title":"Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination","volume":"16","author":"Kvarta","year":"2016","journal-title":"BMC Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13244-019-0726-6","article-title":"Primary central nervous system post-transplant lymphoproliferative disorders: The spectrum of imaging appearances and differential","volume":"10","author":"White","year":"2019","journal-title":"Insights into Imaging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.35100\/EURORAD\/CASE.19335","article-title":"A hit in the target: Bal\u00f3\u2019s concentric sclerosis","author":"Prieto Garc\u00eda","year":"2025","journal-title":"EuroRad"},{"key":"B18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.semnuclmed.2020.12.009","article-title":"18F-FDG PET\/CT for evaluation of post-transplant lymphoproliferative disorder (PTLD)","volume":"51","author":"Song","year":"2021","journal-title":"Semin Nucl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2012.00760.x","article-title":"Structural and metabolic features of two different variants of multiple sclerosis: a PET\/MRI study","volume":"23","author":"Bolcaen","year":"2013","journal-title":"J Neuroimaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24834","article-title":"Primary central nervous system post-transplantation lymphoproliferative disorder: An International Primary Central Nervous System Lymphoma Collaborative Group Report","volume":"116","author":"Cavaliere","year":"2010","journal-title":"Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/j.1432-2277.2011.01282.x","article-title":"IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: A longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment: Cytokine plasma levels during treatment of PTLD","volume":"24","author":"Hinrichs","year":"2011","journal-title":"Transplant Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae391","article-title":"Absence of cerebrospinal fluid pleocytosis in encephalitis","volume":"81","author":"Habis","year":"2025","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2015.06.004","article-title":"Neurologic complications after kidney transplantation","volume":"35","author":"Mour","year":"2015","journal-title":"Semin Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95108","article-title":"Primary central nervous system (CNS) post-transplant lymphoproliferative disorder: a case report","volume":"17","author":"Taitt","year":"2025","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4828-24","article-title":"Post-transplant lymphoproliferative disorder which developed 45 years after kidney transplantation","volume":"64","author":"Nishima","year":"2025","journal-title":"Internal Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000347225","article-title":"Posttransplant lymphoproliferative disorder of the central nervous system","volume":"80","author":"Kempf","year":"2013","journal-title":"Pathobiology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024713","article-title":"Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report","volume":"100","author":"Gao","year":"2021","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1392691","article-title":"A disease warranting attention from neurosurgeons: Primary central nervous system post-transplant lymphoproliferative disorder","volume":"15","author":"Jin","year":"2024","journal-title":"Front Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: Outcomes and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12211","article-title":"Primary CNS posttransplant lymphoproliferative disease (PTLD): An international report of 84 cases in the modern era","volume":"13","author":"Evens","year":"2013","journal-title":"Am J Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04548-2","article-title":"Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry","volume":"100","author":"Zimmermann","year":"2021","journal-title":"Ann Hematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01418-0","article-title":"Important considerations in the diagnosis and management of post-transplant lymphoproliferative disorder","volume":"25","author":"Lee","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.06.009","article-title":"Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients","volume":"94","author":"Francis","year":"2018","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5114\/fn.2017.70487","article-title":"EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system","volume":"3","author":"Xu","year":"2017","journal-title":"Folia Neuropathologica"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10707","article-title":"Characteristics and outcome of post-transplant lymphoproliferative disorders after solid organ transplantation: A single center experience of 196 patients over 30\u00a0years","volume":"35","author":"Vergote","year":"2022","journal-title":"Transplant Int"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1819442\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:23:55Z","timestamp":1780892635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1819442\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":38,"alternative-id":["10.3389\/fonc.2026.1819442"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1819442","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1819442"}}